-
公开(公告)号:US20240158338A1
公开(公告)日:2024-05-16
申请号:US18401076
申请日:2023-12-29
发明人: Ho Wan HAM , Hyun Cheol AN , Hee Joo KIM , Dong Jun KIM , Ja Eun ANN , Dong Yuel KWON , Sung Kyu LEE , Hwan Il JE , Bo Ra LEE , Yeong Rong PARK , Il Soo OH , Dae Woong LEE , Hyeon Jeong IM , Ill Hun CHO
IPC分类号: C07C233/63 , C07C237/26 , C07C257/16 , C07C323/62 , C07C327/46 , C07D401/12 , C07D407/12 , C07D409/12 , C07D413/12 , C07D417/12 , C07D519/00 , H10K50/858 , H10K59/80 , H10K85/60
CPC分类号: C07C233/63 , C07C237/26 , C07C257/16 , C07C323/62 , C07C327/46 , C07D401/12 , C07D407/12 , C07D409/12 , C07D413/12 , C07D417/12 , C07D519/00 , H10K50/858 , H10K59/879 , H10K85/615 , H10K85/653 , H10K85/654 , H10K85/655 , H10K85/656 , H10K85/6565
摘要: A novel compound for a capping layer, and an organic light-emitting device containing the same are disclosed.
-
公开(公告)号:US20190210988A1
公开(公告)日:2019-07-11
申请号:US16059857
申请日:2018-08-09
发明人: Wu-Yan Zhang , Danny LaFrance , Magnus P. Ronn
IPC分类号: C07D295/15 , C07C237/26 , C07C245/20 , C07C231/12 , C07D207/06
CPC分类号: C07D295/15 , C07C231/12 , C07C237/26 , C07C245/20 , C07C2603/46 , C07D207/06
摘要: Provided herein are improved processes for converting C7-amino-substituted tetracyclines to C7-fluoro-substituted tetracyclines, as well as intermediates produced by or used in these processes. In one embodiment, a thermal fluorination method is provided in which a suspension comprising a non-polar organic solvent and a C7-diazo-substituted tetracycline hexafluorophosphate, hexafluoroarsenate or hexafluorosilicate salt, or a salt, solvate or combination thereof, is heated to provide a C7-fluoro-substituted tetracycline, or salt, solvate or combination thereof. In another embodiment, a photolytic fluorination is provided in which a solution comprising an ionic liquid and a C7-diazo-substituted tetracycline tetrafluoroborate, hexafluorophosphate, hexafluoroarsenate or hexafluorosilicate salt, or a salt, solvate or combination thereof, is irradiated to provide a C7-fluoro-substituted tetracycline, or salt, solvate or combination thereof.
-
公开(公告)号:US09884830B2
公开(公告)日:2018-02-06
申请号:US15161165
申请日:2016-05-20
发明人: Andrew G. Myers , Mark G. Charest , Christian D. Lerner , Jason D. Brubaker , Dionicio R. Siegel
IPC分类号: C07D413/00 , C07C237/26 , C07D261/20 , C07D209/56 , C07D209/58 , C07D213/56 , C07D221/18 , C07D235/02 , C07D237/26 , C07D239/70 , C07D241/38 , C07D263/52 , C07D277/30 , C07D277/56 , C07D277/64 , C07D277/66 , C07D307/77 , C07C231/10
CPC分类号: C07D261/20 , C07C231/10 , C07C237/26 , C07D209/56 , C07D209/58 , C07D213/56 , C07D221/18 , C07D235/02 , C07D237/26 , C07D239/70 , C07D241/38 , C07D263/52 , C07D277/30 , C07D277/56 , C07D277/64 , C07D277/66 , C07D307/77
摘要: The tetracycline class of antibiotics has played a major role in the treatment of infectious diseases for the past 50 years. However, the increased use of the tetracyclines in human and veterinary medicine has led to resistance among many organisms previously susceptible to tetracycline antibiotics. The modular synthesis of tetracyclines and tetracycline analogs described provides an efficient and enantioselective route to a variety of tetracycline analogs and polycyclines previously inaccessible via earlier tetracycline syntheses and semi-synthetic methods. These analogs may be used as anti-microbial agents or anti-proliferative agents in the treatment of diseases of humans or other animals.
-
公开(公告)号:US20170334841A1
公开(公告)日:2017-11-23
申请号:US15446831
申请日:2017-03-01
发明人: Yonghong Deng , Louis Plamondon , Cuixiang Sun , Xiao-Yi Xiao , Jingye Zhou , Joyce A. Sutcliffe , Magnus P. Ronn
IPC分类号: C07C311/08 , C07D295/15 , C07C237/26 , C07C307/10 , C07C311/09 , C07C311/13 , C07C311/21 , C07C311/29 , C07C311/44 , C07D233/84 , C07D233/60 , C07D231/18 , C07D223/06 , C07D213/82 , C07D213/74 , C07D213/70 , C07D211/60 , C07D211/54 , C07D209/52 , C07D209/44 , C07D207/16 , C07D207/12 , C07D205/04 , C07D307/64 , C07C2603/46 , C07C2601/02 , C07C2603/40 , C07C2603/44 , C07C2601/16 , C07C2601/04 , C07C2601/14 , C07C2601/08
CPC分类号: C07C311/08 , C07C237/26 , C07C307/10 , C07C311/09 , C07C311/13 , C07C311/21 , C07C311/29 , C07C311/44 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07C2601/14 , C07C2601/16 , C07C2603/40 , C07C2603/44 , C07C2603/46 , C07D205/04 , C07D207/12 , C07D207/16 , C07D209/44 , C07D209/52 , C07D211/54 , C07D211/60 , C07D213/70 , C07D213/74 , C07D213/82 , C07D223/06 , C07D231/18 , C07D233/60 , C07D233/84 , C07D295/15 , C07D307/64
摘要: The present invention is directed to a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (I) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (I) and its therapeutic use.
-
公开(公告)号:US20170305852A1
公开(公告)日:2017-10-26
申请号:US15400674
申请日:2017-01-06
发明人: Xiao-Yi Xiao , Roger B. Clark , Diana Katharine Hunt , Cuixiang Sun , Magnus P. Ronn , Wu-Yan Zhang , Minsheng He
IPC分类号: C07D207/09 , C07D221/18 , C07C237/26 , C07D207/08 , C07D471/04 , C07D295/155
CPC分类号: C07D207/09 , C07C237/26 , C07D207/08 , C07D221/18 , C07D295/155 , C07D471/04
摘要: The present invention is directed to a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (I) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (I), or a pharmaceutically acceptable salt thereof, and its therapeutic use.
-
公开(公告)号:US20160324880A1
公开(公告)日:2016-11-10
申请号:US14962347
申请日:2015-12-08
发明人: Mark L. Nelson , Kwasi Ohemeng
IPC分类号: A61K31/65
CPC分类号: A61K31/65 , C07C235/70 , C07C237/26 , C07C251/48 , C07C255/41 , C07C271/22 , C07C271/54 , C07C271/58 , C07C275/42 , C07C275/54 , C07C279/18 , C07C311/06 , C07C311/08 , C07C333/08 , C07C335/22 , C07C381/10 , C07C2601/08 , C07C2601/10 , C07C2601/16 , C07C2603/46 , C07D295/155 , C07D295/185 , C07D317/60 , C07F9/2475 , C07F9/4006
摘要: The present invention pertains, at least in part, to novel substituted 4-dedimethylamino tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for minocycline and tetracycline compounds in general, such as blocking tetracycline efflux and modulation of gene expression.
-
公开(公告)号:US09416097B2
公开(公告)日:2016-08-16
申请号:US13599116
申请日:2012-08-30
申请人: Zita Mendes , Jose Rafael Antunes , Susana Marto , William Heggie
发明人: Zita Mendes , Jose Rafael Antunes , Susana Marto , William Heggie
IPC分类号: C07C237/26
CPC分类号: C07C237/26
摘要: The invention provides crystalline minocycline base. In particular, three crystalline polymorphic forms, designated Form I, Form II and Form III, of minocycline base are provided. These are characterized by XRD and IR data. Processes for preparing the new polymorphic forms are also provided. For example, Form I is prepared by dissolving and/or suspending amorphous minocycline base in an organic solvent chosen from ethers followed by crystallization from the mixture.
摘要翻译: 本发明提供了结晶米诺环素碱。 特别地,提供了三环结构的多晶型形式,称为米诺环素碱的I型,II型和III型。 其特征在于XRD和IR数据。 还提供了制备新多晶型体的方法。 例如,通过将无定形米诺环素碱溶解和/或悬浮在选自醚中的有机溶剂中,然后从混合物中结晶来制备形式I。
-
公开(公告)号:US20160039749A1
公开(公告)日:2016-02-11
申请号:US13901525
申请日:2013-05-23
IPC分类号: C07C237/26
CPC分类号: C07C237/26 , C07C237/24 , C07C2602/10 , C07C2603/46 , Y10S514/903
摘要: 11a,12-dehydrotetracycline compounds are described.
摘要翻译: 描述了11a,12-脱氢四环素化合物。
-
公开(公告)号:US20160031802A1
公开(公告)日:2016-02-04
申请号:US13936941
申请日:2013-07-08
IPC分类号: C07C237/26 , C07D265/12 , C07D317/54
CPC分类号: C07C237/26 , A61K31/65 , C07D265/12 , C07D317/54 , Y02A50/411
摘要: The present invention pertains to novel 3, 10, and/or 12a-substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for minocycline and tetracycline compounds in general, such as blocking tetracycline efflux and modulation of gene expression.
摘要翻译: 本发明涉及新的3,10和/或12a取代的四环素化合物。 这些四环素化合物可用于治疗多种四环素化合物反应状态,例如细菌感染和肿瘤,以及其他已知的米诺环素和四环素化合物的一般应用,例如阻断四环素外排和调节基因表达。
-
公开(公告)号:US09012433B2
公开(公告)日:2015-04-21
申请号:US13686639
申请日:2012-11-27
发明人: Paul Abato , Todd Bowser
IPC分类号: C07C237/26 , C07D207/20 , C07D211/14 , C07D239/26 , C07D265/30 , C07D207/50 , C07D231/12 , C07D239/20 , C07D241/12 , C07D261/02 , C07D261/04 , C07D263/32 , C07D265/02
CPC分类号: C07C237/26 , C07C2603/46 , C07D207/20 , C07D207/50 , C07D211/14 , C07D231/12 , C07D239/20 , C07D239/26 , C07D241/12 , C07D261/02 , C07D261/04 , C07D263/32 , C07D265/02 , C07D265/30 , C07D295/13 , C07D307/52
摘要: The present invention pertains to tetracycline compounds of formula (VIIa): R5*, R5*′, R7r*, and R9m* are defined herein. These tetracycline compounds can be used to treat tetracycline compound-responsive states, such as multiple sclerosis and rheumatoid arthritis.
摘要翻译: 本发明涉及式(VIIa)的四环素化合物:R5 *,R5 *',R7r *和R9m *在本文中定义。 这些四环素化合物可用于治疗四环素化合物反应状态,例如多发性硬化和类风湿性关节炎。
-
-
-
-
-
-
-
-
-